Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Pfizer recalls Dopamine HCl Inj.

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • Dopamine HCl Inj.
Company
Pfizer
Where it was sold

US Nationwide.

Nationwide

Units affected
N/A
About this recall
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.